These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7088754)

  • 21. Efficacy of Metronidazole in experimental Bacteroides fragilis otitis media.
    Thore M; Sjöberg W; Burman LG; Holm SE
    Acta Otolaryngol; 1985; 99(1-2):60-6. PubMed ID: 3976396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteroides fragilis meningitis successfully treated with metronidazole after a previous failure with thiamphenicol.
    Soriano F; Aguado JM; Tornero J; Fernandez-Guerrero ML; Gómez-Garcés JL
    J Clin Microbiol; 1986 Sep; 24(3):472-3. PubMed ID: 3760141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Case of Native Joint Septic Arthritis Caused by Bacteroides fragilis.
    Hua DT; Spiegel J; Fu PY; Yuchno D
    Am J Case Rep; 2021 Dec; 22():e934266. PubMed ID: 34965243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1978 Nov; 16(5):387-417. PubMed ID: 363399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the pharmacodynamic activity of cefotaxime plus metronidazole with cefoxitin and ampicillin plus sulbactam.
    Sullivan MC; Nightingale CH; Quintiliani R; Sweeney KR
    Pharmacotherapy; 1995; 15(4):479-86. PubMed ID: 7479201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacteraemia due to Bacteroides fragilis with reduced susceptibility to metronidazole.
    Elsaghier AA; Brazier JS; James EA
    J Antimicrob Chemother; 2003 Jun; 51(6):1436-7. PubMed ID: 12746378
    [No Abstract]   [Full Text] [Related]  

  • 27. The action of metronidazole on anaerobic bacilli and similar organisms.
    Baines EJ; McFadzean JA
    Adv Pharmacol Chemother; 1981; 18():223-72. PubMed ID: 7034504
    [No Abstract]   [Full Text] [Related]  

  • 28. Metronidazole single versus multiple daily dosing in serious intraabdominal/pelvic and diabetic foot infections.
    Wang S; Cunha BA; Hamid NS; Amato BM; Feuerman M; Malone B
    J Chemother; 2007 Aug; 19(4):410-6. PubMed ID: 17855185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteroides fragilis: a case study of bacteremia and septic arthritis.
    Martin T; Aziz H
    Clin Lab Sci; 2009; 22(3):131-5. PubMed ID: 19827405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacodynamics of pulse dosing versus standard dosing: in vitro metronidazole activity against Bacteroides fragilis and Bacteroides thetaiotaomicron.
    Ibrahim KH; Gunderson BW; Hermsen ED; Hovde LB; Rotschafer JC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4195-9. PubMed ID: 15504841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of anaerobic infections: an overview.
    Finegold SM
    Scand J Infect Dis Suppl; 1985; 46():89-95. PubMed ID: 3865355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative antibacterial efficacy of clindamycin and metronidazole against Bacteroides fragilis in vitro and in experimentally infected mice.
    Dijkmans BA; Vaishnav J; Mattie H
    Chemotherapy; 1985; 31(4):297-303. PubMed ID: 4028873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metronidazole. A therapeutic review and update.
    Freeman CD; Klutman NE; Lamp KC
    Drugs; 1997 Nov; 54(5):679-708. PubMed ID: 9360057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synovial fluid L-lactic acid in acute arthritis of the adult knee joint.
    Kortekangas P; Peltola O; Toivanen A; Aro HT
    Scand J Rheumatol; 1995; 24(2):98-101. PubMed ID: 7747151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates.
    Schaumann R; Petzold S; Fille M; Rodloff AC
    Infection; 2005 Oct; 33(5-6):368-72. PubMed ID: 16258869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Septic arthritis caused by Bacteroides fragilis.
    Rosenkranz P; Lederman MM; Gopalakrishna KV; Ellner JJ
    Rev Infect Dis; 1990; 12(1):20-30. PubMed ID: 2405467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bactericidal activity of tinidazole. An in vitro comparison of the effects of tinidazole and metronidazole against Bacteroides fragilis and other Anaerobic bacteria.
    Jokipii AM; Jokipii L
    Chemotherapy; 1977; 23(1):25-31. PubMed ID: 318974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of metronidazole on Escherichia coli in the presence of Bacteroides fragilis: an investigation in mice.
    Reznikov M; McDonald PJ
    Chemotherapy; 1983; 29(3):225-9. PubMed ID: 6347547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of metronidazole as determined by bioassay.
    Ralph ED; Clarke JT; Libke RD; Luthy RP; Kirby WM
    Antimicrob Agents Chemother; 1974 Dec; 6(6):691-6. PubMed ID: 4451343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute arthritis: predictive factors and current practice in the approach to diagnosis and management across two hospitals in Sydney.
    Pavic K; Pandya J; Sebak S; Shetty A; Spencer D; Manolios N
    Intern Med J; 2018 Sep; 48(9):1087-1095. PubMed ID: 29756282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.